Options Volatility and Implied Earnings Moves This Week, October 26 – October 30, 2026
This week, several major companies will be reporting earnings. Among them are Amazon (AMZN), Microsoft (MSFT), Alphabet Class A (GOOGL), Alphabet C...
Abbvie Inc. (ABBV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 132,173 | $34,575,052 | -6% | 1.86% |
| 2. | Polaris Capital Management Bernard Horn | 66,394 | $17,368,006 | -7% | 1.82% |
| 3. | Bailard Inc Thomas Bailard | 55,719 | $14,575,730 | +1% | 0.29% |
| 4. | Hourglass Capital Kenneth A. Moffet | 22,210 | $5,809,914 | -33% | 1.19% |
| 5. | Sivik Global Healthcare Krishen Sud | 22,000 | $5,754,980 | +47% | 3.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.00 | 1,550 | $106,950.00 | 17,644 | 2020-03-20 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-20 | Filing | |
| $67.50 | 800 | $54,000.00 | 16,094 | 2020-03-20 | Filing | |
| $68.18 | 2,200 | $150,004.80 | 15,294 | 2020-03-18 | Filing | |
| $69.00 | 750 | $51,750.00 | 16,844 | 2020-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $250.00 | 32,710 | $8,177,500.00 | 74,430 | 2026-08-14 | Filing | |
| $233.56 | 5,230 | $1,221,518.80 | 2,654 | 2026-03-04 | Filing | |
| $235.26 | 2,600 | $611,676.00 | 4,619 | 2026-03-02 | Filing | |
| $234.66 | 10,291 | $2,414,886.06 | 7,219 | 2026-03-02 | Filing | |
| $233.51 | 5,777 | $1,348,987.27 | 17,510 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,706,187 | $969,501,461 | 1.16% | |
| 2. | 1,694,419 | $443,243,066 | 0.43% | |
| 3. | 749,451 | $196,048,988 | 7.83% | |
| 4. | 728,805 | $190,648,100 | 4.72% | |
| 5. | 763,184 | $180,230,813 | 0.27% |
News See All
The Week That Was, The Week Ahead: Macro and Markets, October 25
U.S. stocks finished Friday lower as rising oil prices and renewed inflation concerns weighed on Wall Street. The Dow Jones Industrial Average (DJI...
Jim Cramer and Ken Fisher Like This Healthcare Stock
With AI stocks making waves, some prudent investors are looking at healthcare names to diversify amid concerns about an AI data center slowdown. AbbVie Inc.
Top 10 Stocks Jim Cramer and Billionaire Ken Fisher Like
Billionaire Ken Fisher and Jim Cramer come from very different worlds. Cramer is the fiery CNBC host who talks fast and keeps the show moving.
AbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story?
AbbVie Inc. (NYSE:ABBV) and AstraZeneca PLC (NYSE:AZN) are both delivering earnings growth, but their latest results reveal different strengths.
11 Best Cancer Stocks to Invest In Now
Cancer’s Burden Keeps the Search for Better Treatments Urgent For cancer patients, progress means more time, fewer side effects, and a better chance of recovery.
AbbVie vs. Merck: Which Pharma Stock Offers Better Value?
AbbVie Inc. (NYSE:ABBV) and Merck & Co., Inc.
AbbVie is Outperforming the Market this Year So Far. Is Its 16.4x Valuation Attractive?
AbbVie Inc. (NYSE:ABBV) is delivering strong returns this year, with shares surging by over 23% year-to-date. In comparison, the broader market has returned nearly 13% in the same period.
Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?
Pfizer Inc. (NYSE:PFE) trades at a considerable discount to AbbVie Inc. (NYSE:ABBV), despite both companies reporting growth in important parts of their pharmaceutical portfolios.
Hedge Fund Resource Center